DE60334200D1 - Verfahren zur messung von neprilysinaktivität - Google Patents
Verfahren zur messung von neprilysinaktivitätInfo
- Publication number
- DE60334200D1 DE60334200D1 DE60334200T DE60334200T DE60334200D1 DE 60334200 D1 DE60334200 D1 DE 60334200D1 DE 60334200 T DE60334200 T DE 60334200T DE 60334200 T DE60334200 T DE 60334200T DE 60334200 D1 DE60334200 D1 DE 60334200D1
- Authority
- DE
- Germany
- Prior art keywords
- activity
- neprilysin
- measuring
- present
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002126257 | 2002-04-26 | ||
JP2002261250 | 2002-09-06 | ||
PCT/JP2003/005239 WO2003091449A1 (fr) | 2002-04-26 | 2003-04-24 | Methode de mesure de l'activite de la neprilysine |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60334200D1 true DE60334200D1 (de) | 2010-10-28 |
Family
ID=29272368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60334200T Expired - Lifetime DE60334200D1 (de) | 2002-04-26 | 2003-04-24 | Verfahren zur messung von neprilysinaktivität |
Country Status (7)
Country | Link |
---|---|
US (2) | US7572574B2 (de) |
EP (1) | EP1500707B1 (de) |
AT (1) | ATE481498T1 (de) |
AU (1) | AU2003235113A1 (de) |
CA (1) | CA2483525C (de) |
DE (1) | DE60334200D1 (de) |
WO (1) | WO2003091449A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090023794A1 (en) * | 2005-10-21 | 2009-01-22 | Caritas St. Elizabeth Medical Center Of Boston, Inc. | Use of Sumoylation Inhibitors for the Treatment of Neurodegenerative Disease |
US9097727B2 (en) | 2010-03-03 | 2015-08-04 | Kyoto University | Method for diagnosing a protein misfolding disease using nerve cells derived from iPS cells |
US9074238B2 (en) | 2011-05-08 | 2015-07-07 | Academia Sinica | Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease |
JP7099717B2 (ja) * | 2019-09-30 | 2022-07-12 | 株式会社理研バイオ | ソマトスタチン受容体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990010715A1 (en) * | 1989-03-07 | 1990-09-20 | Molecular Biosystems, Inc. | In-situ hybridization in suspension for detection or separation of cells |
IE76319B1 (en) | 1990-07-23 | 1997-10-22 | Becton Dickinson Co | Preservation of cells as controls or standards in cellular analysis |
JP4175678B2 (ja) | 1996-06-07 | 2008-11-05 | 武田薬品工業株式会社 | 新規ペプチド、その製造法および用途 |
CA2260376A1 (en) * | 1999-02-11 | 2000-08-11 | Universite De Montreal | New metalloproteases of the neprilysin family |
-
2003
- 2003-04-24 AT AT03747225T patent/ATE481498T1/de not_active IP Right Cessation
- 2003-04-24 EP EP03747225A patent/EP1500707B1/de not_active Expired - Lifetime
- 2003-04-24 DE DE60334200T patent/DE60334200D1/de not_active Expired - Lifetime
- 2003-04-24 WO PCT/JP2003/005239 patent/WO2003091449A1/ja active Application Filing
- 2003-04-24 CA CA2483525A patent/CA2483525C/en not_active Expired - Fee Related
- 2003-04-24 US US10/512,588 patent/US7572574B2/en not_active Expired - Fee Related
- 2003-04-24 AU AU2003235113A patent/AU2003235113A1/en not_active Abandoned
-
2009
- 2009-06-24 US US12/491,120 patent/US20090298775A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003091449A1 (fr) | 2003-11-06 |
EP1500707A4 (de) | 2007-05-09 |
EP1500707A1 (de) | 2005-01-26 |
US20090298775A1 (en) | 2009-12-03 |
ATE481498T1 (de) | 2010-10-15 |
US7572574B2 (en) | 2009-08-11 |
EP1500707B1 (de) | 2010-09-15 |
CA2483525A1 (en) | 2003-11-06 |
US20060008842A1 (en) | 2006-01-12 |
CA2483525C (en) | 2013-01-22 |
AU2003235113A8 (en) | 2003-11-10 |
AU2003235113A1 (en) | 2003-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE283485T1 (de) | Verfahren zur diagnose und zur charakterisierung von schlaganfall | |
EP1302542A4 (de) | Neues, physiologisch aktives peptid und dessen verwendung | |
ATE520981T1 (de) | Diagnose und überwachung von krankheiten | |
DE60326259D1 (de) | Neue fructosylpeptidoxidase und deren nutzung | |
EA200800879A1 (ru) | Агонисты ppar гамма для улучшения когнитивной функции у apoe4 отрицательных пациентов | |
ATE480182T1 (de) | Messung der konzentration von substanzen in lebenden organismen mittels mikrodialyse | |
CY1108182T1 (el) | Μεσα εντοπισμου του παθολογικου μετασχηματισμου της πρωτεϊνης app και εφαρμογες τους | |
ATE298890T1 (de) | Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker | |
NO20052992L (no) | Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom. | |
DK2157192T3 (da) | Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner) | |
ATE376428T1 (de) | Metallkomplexverbindungen | |
ATE551357T1 (de) | Markerpeptid für die alzheimer-krankheit | |
DE3751169D1 (de) | Zusammensetzungen und Verfahren zur Synthese und Analyse von Enkephalinase. | |
ATE390939T1 (de) | In-vivo verfahren zur messung von auf der haut oder dessen komponenten bindenden aktiven chemischen substanzen | |
ATE422671T1 (de) | Verfahren zur diagnose von morbus alzheimer | |
DK0507831T3 (da) | Fremgangsmåde til detektion af knogle- og bindevævssygdomme hos mennesker og dyr | |
DE60207612D1 (de) | Verbindungen zur bilddarstellung der alzheimer-krankenheit | |
DE60334200D1 (de) | Verfahren zur messung von neprilysinaktivität | |
DK1791973T3 (da) | DOT1-histonmethyltransferaser som et target til at identificere terapeutiske midler mod leukæmi | |
DK1373502T3 (da) | Dopaminerge neuronale overlevelsesfremmende faktorer og avendelser heraf | |
DK0764273T3 (da) | Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose | |
DE50007635D1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
DE60221273D1 (de) | Verfahren zur steigerung der expression von menschlichen tnf-rezeptor | |
DE602004011478D1 (de) | Anzeige der genauigkeit einer quantitativen analyse | |
ATE253223T1 (de) | Verfahren und materialien zur diagnose instabiler angina |